Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [683]
News [2335]
Articles [179]
Editorials [6]
Conferences [88]
elearning [22]
GI and gynaecological tumours in the elderly
Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus
GI and gynaecological tumours in the elderly ( Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus )
22 Nov 2016
What are the successes of SIOG?
Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus
What are the successes of SIOG? ( Dr Demetris Papamichael - Cyprus Oncology Centre, Strovolos, Cyprus )
22 Nov 2016
Carcinoid syndrome
Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo...
Carcinoid syndrome ( Dr Rachel Riechelmann - Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil )
12 Oct 2016
LUME study of nintedanib finds improved PFS, but no overall survival boost
Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
LUME study of nintedanib finds improved PFS, but no overall survival boost ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
12 Oct 2016
Left versus right sided GI tumour response in the CRYSTAL trial
Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium
Left versus right sided GI tumour response in the CRYSTAL trial ( Prof Eric Van Cutsem - University of Leuven, Leuven, Belgium )
10 Oct 2016
Looking for new pathways in colorectal cancer
Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark
Looking for new pathways in colorectal cancer ( Prof Nils Brünner - Copenhagen University, Copenhagen, Denmark )
10 Oct 2016
Olaparib and paclitaxel for 2nd line gastric cancer therapy
Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea
Olaparib and paclitaxel for 2nd line gastric cancer therapy ( Dr Yung-Jue Bang - Seoul National University, Seoul, South Korea )
10 Oct 2016
Innovative uses of kinase inhibitors in cancer
Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
Innovative uses of kinase inhibitors in cancer ( Dr Jordi Rodón - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain )
10 Oct 2016
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI...
Dr Arndt Stahler - University of Munich, Munich, Germany
A potential prognostic biomarker of chemoresistance in mCRC treated with FUFIRI or mIrOx (FIRE1) ( Dr Arndt Stahler - University of Munich, Munich, Germany )
9 Oct 2016
Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer
Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France
Adjuvant cetuximab in the PETACC8 trial for stage III colon cancer ( Prof Julien Taïeb - Georges Pompidou European Hospital, Paris, France )
8 Oct 2016
Chemoprevention of platelet crosstalk in cancer
Prof Carlo Patrono - Catholic University School of Medicine, Rome, Italy
Chemoprevention of platelet crosstalk in cancer ( Prof Carlo Patrono - Catholic University School of Medicine, Rome, Italy )
4 Aug 2016
Update on CaPP3 in high risk populations
Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK
Update on CaPP3 in high risk populations ( Prof Sir John Burn – Institute of Genetic Medicine, Newcastle, UK )
4 Aug 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation